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Abstract: 
Background:Carbapenem resistance in Pseudomonas aeruginosa is particularly worrisome because 
this class of β-lactam represents the last therapeutic resource for control of bacterial infection. 
Objectives This study aimed to detect the frequency of bla OXA-48 resistance gene among 
Pseudomonas aeruginosa clinical isolates during the period from November 2018 to November 
2019. 
Methods: Hundred Pseudomonas aeruginosa clinical isolates, 81 carbapenems (imipenem 
meropenem) resistant and 19 carbapenems sensitive were collected from Omdurman Teaching 
Hospital, Fedail Hospital and Soba Teaching Hospital in Khartoum State-Sudan. All isolates were 
re-identified using conventional bacteriological techniques, their susceptibility to carbapenems were 
tested using Kirby-Bauer method for confirmation. All isolates were investigated for the presence of 
the bla OXA-48 gene using conventional PCR technique. 
Results: 60 (60.0%) out of 100 Pseudomonas aeruginosa clinical isolates were positive for 
blaOXA-48 gene. Out of 81 carbapenem resistant isolates 54(66.7%) were positive for bla OXA-48 
gene, while among the (19) carbapenem sensitive isolates 6 (31.6%) were positive for blaOXA-48 
gene. There was statistically significant association between carbapenem resistant isolates and the 
presence of blaOXA-48 gene (P-value = 0.006). 
Wound swabs were the predominant clinical samples detected harboring bla OXA-48 gene both 
among the sensitive 5 (83.3%) and carbapenem resistant isolates 29(53.7) (P.value> 0.05). 
Conclusion: Our findings revealed high frequency of bla OXA-48 among carbapenem resistant 
isolates so identification of bla OXA-48 producing strains and taking efforts to reduce the rate of 
transferring these gene between the different strains is essential for optimization of  therapy and 
improves of patients outcomes.  
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Pseudomonas aeruginosa (P.aeruginosa) is gram negative bacterium.
(1)
. It is a lethal opportunistic 
pathogen that is a leading cause of morbidity and mortality in immunocompromised individuals 
(2)
. 
It is rarely found in the microbiota of healthy humans 
(3)
.The colonization rate by P.aeruginosa 
significantly increases (reaching up to 80％) in patients with chronic illnesses (e.g cystic fibrosis, 
severe burns) or extensive exposure to health care facilities involving interruption of protective 
barriers 
(4, 5)
. It has an intrinsic resistance to wide range of antimicrobial agents and a high capacity 
to attain resistance mutations and mobile genetic elements 
(6)
. Elimination of P. aeruginosa has 
become increasingly difficult due to its remarkable capacity to resist antibiotics 
(2)
.  
Carbapenem resistance in P.aeruginosa is particularly worrisome because this class of β-lactam 
represents the last therapeutic resource for control of bacterial infection 
(7)
. Although porins loss and 
efflux pumps may contribute to the phenotype of carbapenem resistance in P.aeruginosa, yet the 




Carbapenemase producing carbapenem resistance enterobacteracea ( enterobabacteriacae) (CP- 
CRE) that directly break down carbapenem have been classified to various types such as class A β-
lactamase (NMC, IMI, SMS, MKPC, GES), class B  β-lactamase (IMP, VIM, SPM, NDM) and 
class D β-lactamase (OXA-48) 
(8)
. In recent years, the emergence of diverse carbapenemase in 
members of the family  Enterobacteriaceae has become a major challenge for health care system 
(9)
.   
BlaOXA-48 gene is a class D β-lactamase that possesses the ability to hydrolyze carbapenems as 
well as Cloxacillin and Penicillin 
(10)
. Studies done by Carrër , et al., (2010)  indicated that the 
blaOXA-48 gene has been found in plasmid and located between two identical insertion sequences, 
IS999, forming the composite transposon Tn 1999s 
(11)
. The genetic environment of blaOXA-48 
was investigated by PCR with primers specific for insertipon sequence IS1999 and for the 5′ part of 
blaOXA-48 
(11)
. Recently, Nordmann et al described a new inhibitor-based biochemical assay for 
carbapenemase detection 
(12)
. But detection of OXA-48 and related enzymes remains problematic, 
as no specific inhibitor is available. Temocillin resistance was suggested as an indicator of OXA-48 
production but not for OXA-48 confirmation 
(13-15)
.  
The first case of resistance mediated by OXA-48 was identified in 2001 from multi-drug resistance    
Klebsiella pneumoniae in Istanbul Turkey 
(16)
. Several cases of OXA-48 producing organisms like 
Pseudomonas, E.coli and Citrobacter were reported in patients from or have relation with Turkey 
(17)
.Several isolates producing OXA-48 have been involved as a source of nosocomial outbreaks 
(18, 
19)
.Outbreak of OXA-48 was reported worldwide, disseminating from Middle Eastern countries and 
North Africa. Sporadic cases have been reported in Lebanon, Oman, Saudi Arabia and Kuwait. In 
Africa mostly in Northern African countries of Egypt, Tunisia, Libya and Morocco 
(20)
.And little is 
known about this problem in Sudan, as a rapid and reliable detection of carbapenemases is desirable 
in order to limit the spread of these enzymes. Thus the present study aimed to investigate the 
frequency of blaOXA-48 resistant gene among carbapenem resistance P. aeruginosa. 
 
Materials and Methods: 
Design and setting 
A descriptive - cross sectional study was conducted in different Khartoum State hospitals, Sudan  
(Omdurman Teaching Hospital, Fedail Hospital and Soba Teaching Hospital) during the period 
from November 2018 to November 2019. A total of 100 Pseudomonas aeruginosa clinical isolates 
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of known carbapenem susceptibility from different types of clinical samples   (wound swabs, urine, 
ear swabs, sputum and high vaginal swabs) were included in this study. They represented 81 
carbapenems (imipenem meropenem) resistant and 19 carbapenems sensitive. 
 Pseudomonas aeruginosa clinical isolates of known resistant and sensitive to both routinely used 
carbapenem (Meropenem and Imipenem) antibiotics were included in this study and any clinical 
isolates resist or sensitive to only one carbapenem antibiotics was excluded from this study. The 
approval and informed consent was obtained from Faculty and Department of Medical 
Microbiology management, Al-Neelain University and informed consent was taken from  hospitals 
included in this study. 
Phenotypic methods 
The fresh cultured colonies of P.aeruginosa clinical isolates were sub-cultured on nutrient agar and  
MacConkey agar media to ensure purity and optimal growth. Then they were re- identified using 
routine culture techniques and their susceptibility to carbapenems were tested using Kirby-Bauer 
method for confirmation. 
DNA extraction 
Bacterial DNA was extracted by using boiling method. All bacterial strains were sub cultured on 
nutrient agar and the overnight pure bacterial growth were used. Three colonies were emulsified in 
Eppendorf tubes containing 200µl of the distilled water and boiled at 100 ºC for 30 minutes then 
centrifuged at 12000 rmp for 15 minutes. The supernatant containing DNA was transferred to new 
Eppendorf tubes and stored at -20°C 
(21)
  
PCR amplification procedure  
PCR was carried out for all isolates by using specific primer for OXA-48 gene F 
5'GCGTGGTTAAGGATGAACA 3' R 5'CATCAAGTTCAACCCAACCG 3' of amplicon size of 177 
bp 
(22)
.  Amplification was performed at final volume 25 µl (5µl Mater mix, 5µl from DNA, 2µl 
primer and 13µlD.W).The PCR cycling conditions were as follows: an initial denaturation step of  
10 min at 94℃ followed by 35 cycles of 30 s at 94℃, 30 s at 55℃ and 30s at 72℃,with a final 
extension of 10 min ,(Tc-412,UK) thermo cycler machine was used. 
PCR products was separated on 2% agarose gel by electrophoresis to detect specific amplified 
product by comparing with standard molecular weight marker 100 base pair (DNA ladder) 5µl of 
PCR product was loaded into the well. Electrophoresis was carried out at 100 Volts, 60 AMP and 
30 minutes.  
The amplified products of the study samples were visualized by Trans -illuminator. Photographed 
by a digital camera and transferred to computer data for labeling and storage.  
  
Results: 
Hundred (100) P.aeruginosa clinical isolates were collected from different hospitals in Khartoum 
State, Sudan during the period from November 2018 to November 2019. They were obtained from 
different clinical samples. They represented (57) wound swabs, (24) urine, (3) ear swabs, (6) 
sputum and (10) high vaginal swabs (Table 1).Their identification was confirmed using 





















Table 1: Distribution of Pseudomonas aeruginosa clinical isolates according to type of 
specimens. 
Specimens Frequency (%) 
Wound swab 57 (57.0%) 
Urine 24 (24.0%) 
High vaginal swab 10 (10.0%) 
Sputum 6 (6.0%) 
Ear swab 3 (3.0%) 
Total 100 (100.0%) 
  
 
Carbapenem (Meropenem and Imipenem) susceptibility testing using disc diffusion method showed 
that 81(81.0%) of isolates were Meropenem and Imipenem resistant, While 19 (19.0%) were 




 Figure 1: Distribution of carbapenem susceptibility tests among the 100 clinical isolates 
of P.aeruginosa. 
 
Based on PCR result (Figure 2), 60 (60.0%) out of 100 clinical isolates of Pseudomonas aeruginosa 
were positive for blaOXA-48 resistance gene (Figure 3). 
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Figure 2: Amplified DNA under ultra violet light machine showing
bla OXA-48 positive result. Lane 1, DNA leader 100 bp , ;Lanes 2,3,
4, 5 negative samples. Land 6 was a positive sample (typical band
size of 177 bp corresponding to the molecularsize of bla OXA-48
gene).






Figure 3: Frequency of blaOXA-48 resistance gene among the 100 Psaeudomonas aruginosa 
clinical isolates. 
 
Out of 81 carbapenem resistant strains 54(66.7%) were positive for bla Oxa-48 resistance gene, 
while among the 19 sensitive strains 6 (31.6%) were positive for blaOXA-48 gene (Table 2). There 
was a statistically significant association between carbapenem susceptibility and the frequency of 
blaOXA-48 gene with (P-value =0.006).  
Table 2: Frequency of bla OXA-48 gene according to carbapenem (Meropenem, Imipenem) 
susceptibility testing  
Carbapenem  
susceptibility test 
OXA-48 gene Total 
Present Absent 
Resistance 54 (66.7%) 27 (33.3%) 81 (100.0%) 
Sensitive 6 (31.6%) 13 (68.4%) 19 (100.0%) 
Total 60 (60.0%) 40 (40.0%) 100 (100.0%) 
P-value  0.006   
Table (3) showed that the frequency of blaOXA-48 gene among the resistant strains was most 
common among wound swabs 29 (53.7%) followed by urine 14 (25.9%) (P value > 0.05), similar, it 
was most frequent among wound swabs 5 (83.3%) followed by urine 1 (16.7%) among the sensitive 
strains (P value > 0.05) (Table 3-4).There was a statistically insignificant association between the 
frequency of blaOXA-48 gene and the type of specimens. 
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Table 3: Frequency of carbapenemase bla OXA-48 gene among the carbapenem resistant 
strains of P.aerginosa according to the type of specimens 
Specimens OXA-48 gene Total 
Present Absent 
Wound swab 29 (53.7%) 15 (55.6%) 44 (54.3%) 
Urine 14 (25.9%) 7 (25.9%) 21 (25.9%) 
Ear swab 2 (3.7%) 1 (3.7%) 3 (3.7%) 
Sputum 5 (9.3%) 1 (3.7%) 6 (7.4%) 
High vaginal swab 4 (7.4%) 3 (11.1%) 7 (8.6%0 
Total 54 (100.0%) 27 (100.0%) 81 (100.0%) 
P-value  0.903   
 
Discussion: 
Carbapenem resistance mediated by carbapenemases is an important issue in infection control 
programs 
(23)




In the present study it was found that among the total (100) clinical isolates, the most common 
isolates were from wound swab specimens, because Pseudomonas aeruginosa leading to cause of 
health care acquired infections most commonly associated with wound infections 
(25)
.   
In the current study the frequency of bla OXA-48 resistance gene was 60% out of 100 
Pseudomonas aeruginosa clinical isolates. Our result was higher than that study done in Sudan by 
Mohamed ,et al., (2018) 
(26)
  it was  found   out of 67 P. aerugenosa clinical isolates 22.4% were 
positive for bla OXA-48 resistance gene by real time PCR, This may be due to differences in 
sample size. 
  Among (81) carbapenem resistant isolates 54 (66.7%) were positive for blaOXA-48 resistance 
gene (P value < 0.05). It was noted that the absence of bla OXA-48 resistance gene among  the 
27(33.3%) resistant strains may be due to impermeability , which arise via the loss of the Opr D 
porin , the up-regulation of active efflux pump system present in cytoplasmic membrane of the 
bacteria and  bla OXA-48 resistance gene encoded on mobile genetic elements,  it has ability to 
transfer from one bacterium to another 
(27)
.Or they may possess other type of carbapenemase 
enzymes rather than bla OXA-48 gene. While among the (19) carbapenem sensitive isolates, 6 
(31.6%) were positive for bla OXA-48 resistance gene. The presence of resistance gene among the 
sensitive strains  may indicates  that there might be a hidden  bla OXA-48 gene among them which 
cannot be diagnosed by phenotypic  tests as mentioned in study done by Adam et al. (2018) 
(28)
. The 
present study showed that there was a statistically insignificant association between the frequency 
of blaOXA-48 gene and the type of specimens, although there was a high frequency of bla OXA-48 
resistance gene among wound swabs than other type of specimens.  This may be due to the large 
sample size of wound swabs compared with other specimens, and P.aeruginosa was most 
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In the present work, the significant high frequency of bla Oxa-48 resistance gene among the 
resistance strains may indicates that it is a main source of initiating resistance among these strains, 
while its presence among carbapenem sensitive isolates suggesting the occurrence of silent gene, 
that encoded in a movable genetic elements (plasmid), there for, it play a key role in the transfer of 
horizontal resistance gene from one bacterium to another. Therefore prevention and control 
programs of carbapenem resistant should be performed to prevent the spread of carbapenemase 
producers, which includes appropriate use of antimicrobials and facility-level prevention strategies, 
as recommended by CDC (Centers for Disease Control and prevention). 
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